Express Pharma - Page 519 of 2195 - Express Pharma

Review meeting held on WHO-ICHI Framework, National Health Intervention Codes for ASU

Lupin’s Ankleshwar facility receives EIR from US FDA

MedTherapy details India manufacturing plans for CAR-T and gene therapies

AstraZeneca boosts COVID portfolio with RQ Bio deal

Bert Labs strengthens its pharma capabilities with senior-level appointments

Indoco’s PAT jumps 62 per cent in Q4FY22

Valneva receives EUA from UAE for its inactivated COVID-19 vaccine

Zydus Wellness’s revenue crosses Rs 2,000 crores in FY22

Multiples private equity-led consortium invests Rs 6,850 million in BDR Pharma

AbbVie and Cugene announce collaboration in autoimmune diseases

US FDA-Gujarat FDCA Regulatory Forum to be held from 17th to 19th May

FDA declines to authorise common antidepressant as COVID treatment

Gerresheimer boosts global production capabilities with new facilities in India